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It is widely recognized that extracellular vesicles subserve non-classical signal
transmission in the central nervous system. Here we assess if the astrocyte processes,
that are recognized to play crucial roles in intercellular communication at the synapses and
in neuron-astrocyte networks, could convey messages through extracellular vesicles. Our
findings indicate, for the first time that freshly isolated astrocyte processes prepared from
adult rat cerebral cortex, can indeed participate to signal transmission in central nervous
system by releasing exosomes that by volume transmission might target near or long-
distance sites. It is noteworthy that the exosomes released from the astrocyte processes
proved ability to selectively target neurons. The astrocyte-derived exosomes were proven
positive for neuroglobin, a protein functioning as neuroprotectant against cell insult; the
possibility that exosomes might transfer neuroglobin to neurons would add a mechanism
to the potential astrocytic neuroprotectant activity. Notably, the exosomes released from
the processes of astrocytes maintained markers, which prove their parental astrocytic
origin. This potentially allows the assessment of the cellular origin of exosomes that might
be recovered from body fluids.
Keywords: adult astrocytes, astrocyte processes, cerebral cortex, ex-vivo, exosomes, extracellular vesicles,
neuroglobin, neuron-astrocyte coculturesAbbreviations: CNS, central nervous system; EVs, extracellular vesicles; GFAP, glial fibrillary protein; NGB, neuroglobin;
BSA, bovine serum albumin; MAP-2, microtubule-associated protein 2; PFA, paraformaldehyde; PBS, phosphate buffer
solution; b III Tub, b III Tubulin.
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The relevance of neuron-astrocyte network function in the
intercellular communication in central nervous system (CNS) as
well as in the vulnerability to neurodegenerative and
neuropsychiatric diseases is widely accepted (see Halassa and
Haydon, 2010; Sofroniew, 2015; Verkhratsky et al., 2016). In the
neuron-astrocyte networks the perisynaptic astrocyte processes
function as sensors of transmitters in the extracellular environment
—acted upon by neurotransmitters and gliotransmitters through a
volume transmission mode of communication (see for reviews
Agnati and Fuxe, 2000; Vizi, 2000)—and modulate neural activity
by clearing glutamate and by releasing gliotransmitters (see
Verkhratsky et al., 2016; Cervetto et al., 2018 and references
therein); they also regulate extracellular space volume and coverage
of synapses (Xie et al., 2013). Indeed, they represent the astrocyte
compartment specially devoted to bidirectional neuron-astrocyte
communication in the complex interaction involvingpre- andpost-
synapticelements(thetripartitesynapse;Araqueetal.,1999)withthe
extracellular matrix (the tetrapartite synapse; Thalhammer and
Cingolani, 2014; Agnati et al., 2018) and to regulation of
synapse plasticity.
An increasing amount of evidence indicates that extracellular
vesicles (EVs) operate as carriers of signals in CNS. Intercellular
communication through EVs is generally accepted as a mode of
non-synaptic communication inCNS—the roamer-type of volume
transmission—contributing to the role of the extracellular space in
the signaling diffusion and codification in the brain (Agnati et al.,
2014). Exosomes—EVs of about 30–100nmdiameter, released into
the extracellular spaceupon fusionofmultivesicular bodieswith the
plasma membrane—are recognized to play multiple roles in both
physiological and pathological conditions in CNS (Février and
Raposo, 2004; Raposo and Stoorvogel, 2013 and references
therein). Various CNS cell types, including neurons, microglia
and oligodendroglia, can release exosomes; while cultured
astrocytes have been reported to secrete exosomes (see Taylor et al.,
2007; Guescini et al., 2010; Wang et al., 2011; Wang et al., 2012;
Guitart et al., 2016; Willis et al., 2017; Hira et al., 2018; Pascua-
Maestro et al., 2019; Pei et al., 2019; Xu et al., 2019; see also
Verkhratsky et al., 2016 and Lafourcade et al., 2016), less is known
on the ability of astrocytes to release exosomes in neuron-
astrocyte networks.
Here we investigate on the possibility that the processes of
astrocytes might convey messages in non-classical mode through
EVs. We report for the first time that astrocytic processes freshly
prepared from adult rat cerebral cortex and originating from
astrocytes that have matured in astrocyte-neuron networks, are
provided with structures resembling multivesicular bodies and can
release vesicles, which exhibit the features of exosomes. Therefore,
although their subcellular origin cannot be directly demonstrated,
the vesicles can be considered bona-fide exosomes (from now on,
“exosomes”). Moreover, we report that the exosomes can transport
neuroglobin (NGB). NGB, a protein produced mainly in neurons
within the CNS but also detected in astrocytes, and exhibiting anti-
oxidant, anti-apoptotic, and anti-inflammatory effects, might
function as a neuroprotectant against hypoxic/ischemic insult, b-
amyloid, or H2O2 toxicity (see Guidolin et al., 2014; Guidolin et al.,Frontiers in Pharmacology | www.frontiersin.org 22016; Van Acker et al., 2019 and references therein). Noteworthy,
the exosomes released from the astrocyte processes were able to
selectively target neurons. The finding that astrocytic processes
express and release NGB might contribute additional mechanisms
to the astrocyte neuroprotective potential.MATERIALS AND METHODS
Chemicals and Reagents
Percoll, bovine serum albumin (BSA), poly-L-ornithine, PKH67
fluorescent cell linker kit (catalog number PKH67GL MIDI67),
and all the salts were from Sigma-Aldrich St. Louis, MO USA.
The primary or secondary antibodies were from Sigma-Aldrich
[mouse anti-synaptophysin, catalog number: S5768; rabbit anti-
glial fibrillary protein (GFAP), catalog number: G9269; mouse
anti-GFAP (clone G-A-5), catalog number: G3893; mouse anti-
ezrin, catalog number: E8897; mouse anti-b-actin, catalog
number: A2228; rabbit anti-b III tubulin, catalog number:
SAB4500088], from Synaptic Systems, Goettingen, Germany
[rabbit anti-microtubule-associated protein 2 (MAP2), catalog
number: 188 003], from Merck Millipore Corporation,
Darmstadt, Germany [mouse anti-oligodendrocyte (RIP),
catalog number: MAB1580; mouse anti-integrin-aM (clone
OX-42), catalog number: CBL 1512], from Santa Cruz
Biotechnology Inc, Dallas, TX USA [rabbit anti-NGB (clone
FL-151); catalog number: sc-30144] or from Thermo-Fisher
Scientific Inc, Waltham, MA USA [mouse anti-Alix (clone
3A9), catalog number: MA1-83977; mouse anti-Tsg101 (clone
4A10), catalog number: MA1-23296; Alexa-Fluor 488 or 633
conjugated goat anti-rabbit or anti-mouse secondary
antibodies]. The horseradish peroxidase-linked anti-rabbit or
anti-mouse secondary antibodies were from Cell Signaling
Technology Inc, Danvers, MA USA. Prolong Gold Antifade
Mountant were from Molecular Probes, Eugene, OR USA; the
microporous filters and the polyvinylidene difluoridemembrane
were bought from Merck Millipore Corporation, Darmstadt,
Germany. The mini gel used for western blot were from Bio-Rad
Laboratories, Hercules, CA USA; ECL-PLUS kit was from GE
Healthcare, Milano, Italy; Neurobasal, DMEM, B27, Glutamax,
and Pen-Strepto were from Gibco by Thermo-Fischer
Scientific Inc.
Animals
Adult male rats (200–250 g, Sprague–Dawley) were housed at
constant temperature (22 ± 1°C) and relative humidity (50%)
under a regular light-dark schedule (lights on 7 AM–7 PM).
Food and water were freely available. To prepare primary
neuronal cultures Sprague–Dawley rat embryos at the day 18
of gestation (E18) were used. The pregnant dams were
anes the t i zed and the embryos were ex t rac ted by
caesarian section.
Animal care and experimental procedures complied with the
European Communities Parliament and Council Directive of 22
September 2010 (2010/63/EU) and with the Italian D.L. n. 26/
2014, and were approved by the Italian Ministry of HealthDecember 2019 | Volume 10 | Article 1452
Venturini et al. Exosomes From Astrocyte Processes(protocol number 26768 of November 2012 and protocol
number 75F11.N.6JI of August 2018), in accordance with
Decreto Ministeriale 116/1992. All efforts were made to
minimize the number of animals used and their suffering, and
no in vivo technique was used.
Preparation of Purified Astrocytic
Processes
Purified astrocyte processes (gliosomes) were prepared from the
cerebral cortex of adult male rats. Briefly, after decapitation, the
tissue was rapidly removed and placed in ice-cold medium.
Purified gliosomes were prepared by a discontinuous Percoll
gradient according to Nakamura (Nakamura et al., 1993) as
previously reported (see Cervetto et al., 2018). Briefly, rat
cerebral cortices were homogenized in 10 volumes of 10 mM
Tris/HCl pH 7.4 with 0.32 M sucrose, using a glass-Teflon tissue
grinder (clearance 0.25 mm). The homogenate was centrifuged
(5 min at 4°C and 1,000 g) to remove nuclei and debris and the
supernatant stratified on a discontinuous Percoll gradient (2, 6,
10, and 20% (v/v) in Tris-buffered sucrose) and centrifuged for 5
min at 4°C and 33,000 g. The layer between 2% and 6% (v/v)
Percoll (gliosomal fraction; purified astrocyte processes) was
collected and washed by centrifugation. For release
experiments, purified astrocyte processes were suspended in
standard HEPES medium (mM: NaCl 128, KCl 2.4, MgSO4
1.2, KH2PO4 1.2, CaCl2 1.0, and HEPES 10 with glucose 10,
pH 7.4). Protein determinations were carried out using serum
bovine albumin as the standard (see Cervetto et al., 2018).
Confocal Microscopy on Gliosomes
and Synaptosomes
Immunofluorescence confocal microscopy on gliosomes and
synaptosomes was performed according to sequential staining
methods (see Cervetto et al., 2016; Cervetto et al., 2018). Briefly,
gliosomes and synaptosomes were fixed and permeabilized in 2%
paraformaldehyde (PFA)/0,1% Triton X-100 in phosphate buffer
solution (PBS) pH 7.4 and then incubated in the diluted primary
antibodies in 3% BSA in PBS (over-night, 4°C). The following
primary antibodies were used: mouse anti-synaptophysin
(1:1,000), rabbit anti-GFAP (1:1,000); mouse anti-RIP
(1:10,000), and mouse anti-integrin-aM (1:25). After washing
with PBS the preparations were incubated with the appropriate
Alexa-Fluor 488 or 633 conjugated secondary antibodies
(1:1,000). Gliosomes and synaptosomes were then smeared
onto coverslips with anti-fade mounting medium (ProLong
Gold). Images were collected by means of a three-channel TCS
SP2 laser-scanning confocal microscope (Leica Wetzlar,
Germany) using a plan apochromatic oil immersion objective
60×/numeric aperture 1.43. The ImageJ software (Wayne
Rasband, National Institutes of Health, Bethesda, MD, USA)
was used to count positive particles using 3D-counter object
analyzed application (Threshold = 50 in all the fields—Fiji
ImageJ). The percentage of GFAP, synaptophysin, RIP, and
integrin-aM positive particles was estimated in three to five
non-overlapping fields from three different preparations of
gliosomes and synaptosomes, and are expressed as mean ± SEM.Frontiers in Pharmacology | www.frontiersin.org 3Release Experiments and Extracellular
Vesicle Isolation and Characterization
We collected the EVs released from the astrocyte processes
essentially by applying the method used to collect the
gliotransmitters released from isolated perfused astrocyte
processes (gliosomes) or the neurotransmitters released from
isolated perfused nerve terminals (synaptosomes). Briefly,
gliosomes were stratified on microporous filters (MF-
Millipore™, Thickness: 180µm; Pore size: 0.65µm; Merck-
Millipore) at the bottom of parallel perfusion chambers at 37°
C and continuously perfused (0.5 ml/min) with a standard
medium as described previously (Cervetto et al., 2017; Cervetto
et al., 2018). After 5-min perfusion, perfusate fractions were
collected in a 10-min sample. The perfusate was pelleted by
ultracentrifugation at 110,000 g for 90 min (Guescini et al., 2010)
and the EVs were resuspended i) in PBS to perform nanosight
analysis by using a dynamic light scattering; ii) in loading buffer
for performing western blot analysis; iii) in diluent C, according
to PKH67 kit technical instructions, to be labeled with the
exosome dye PKH67 for assessing their ability to target cells.
Dynamic Light Scattering
To measure the size of the EVs released from astrocyte processes
we performed the nanosight analysis on ultracentrifugation
pellet resuspended in PBS using the Zetasizer Nano ZS90
particle sizer at a 90° fixed angle (Malvern Instruments,
Worcestershire, United Kingdom), as previously described
(Marimpietri et al., 2013). Nanosphere™ size standards with a
mean diameter of 57 ± 4 nm (Thermo Scientific) were used for
particle sizer calibration. The analysis was replicated on three
different samples.
Western Blot
The western blot analysis was performed both on gliosomes,
synaptosomes, and EVs. Proteins were denatured in Laemmli
sample buffer and then subjected to a SDS-polyacrylamide gel
electrophoresis (13% or 4–20% gradient mini gel) 200 V for 50
min (gliosomes: 5–20 µg/lane; synaptosomes: 10µg/lane; EVs:
estimated amount of proteins: 2.53–6.32 µg/lane; Mini-Protean
TGX Gel, Bio-Rad Laboratories), followed by electroblotting
(100 V for 50 min) on polyvinylidene difluoride membrane
(Immobilon-P PVDF; Millipore Corporation). The blot has
been cut probing different regions of the same blot with
multiple antibodies. Immunodetection was performed using
the following primary antibodies: mouse anti-Alix (1:1,000);
mouse anti-Tsg101 (1:800); rabbit anti-NGB (1:300); mouse
anti-GFAP (1:1,000); mouse anti-ezrin (1:500); rabbit anti-
MAP-2 (1:1,000); and rabbit anti-b III tubulin (1:1,000).
Primary antibodies were incubated over-night at 4°C followed
by washing and the application of horseradish peroxidase-linked
anti-rabbit or anti-mouse (Cell Signaling Technology) secondary
antibodies, incubated for 1 h at room temperature. Western blots
were developed with the ECL-PLUS kit (GE Healthcare),
according to the manufacturer's instructions. Band detection
and densitometry were performed using the Chemi-Doc
System and the quantity one software package (Bio-RadDecember 2019 | Volume 10 | Article 1452
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solution (Merck-Millipore Corporation) and re-probed with
mouse anti-b-actin (1:10,000) also to estimate the amounts of
proteins in exosomes. Developed films were analyzed using
specific software (GelDoc; Bio-Rad Laboratories).
Electron Microscopy
Ultrastructural analysis of gliosomes and exosomes was performed
by negative staining method. Briefly, 5µl drops of gliosomes or
purified exosomes were placed onto formvar and carbon-coated
copper grids and adsorbed for 20 min at room temperature. The
excess of buffer was removed by using a filter paper. Then, grids
were fixed in 2%PFA inPBS pH7.2 for 5min andwashed out three
timeson largedropsofdistilledwater.Gridswere then incubated for
5 min at room temperature with 1% aqueous solution of uranyl
acetate. Contrast enhancement was obtained by further incubating
the grids with a mixture of 1% uranyl acetate and 1%
methylcellulose for 5 min. After drying, grids with gliosomes or
exosomes were immediately observed with a CM10 electron
microscope (Philips, Eindhoven, The Netherlands). Digital
images were taken with a Megaview II camera.
Labeling of Exosomes
For immunofluorescence analysis, the exosome pellet was
resuspended in diluent C and stained with the dye PKH67
according to the producer's technical bulletin (Fitzner et al.,
2011). The dye was gently pipetted with the sample, and after 5
min at room temperature, the staining reaction was stopped
bringing the volume up to 35mlwith 10%BSA in PBS. Exosomes
were pelleted by ultracentrifugation (110,000 g for 90 min) and
resuspended in 150 µl of Neurobasal. In parallel as control
condition, we prepared the control samples with equal
volumes of PBS plus the same amount of diluent C, PKH67
dye, 10%BSA and PBS, and by omitting the exosomes, to exclude
any non-specific labeling of cells by micelles of the aliphatic dye
or by the excess of dye.
Neuron-Astrocyte Co-Cultures
Primary cortical cells were derived from Sprague–Dawley rat
embryonic day 18 (E18). Culture preparation was performed as
previously described (Chiappalone et al., 2006). Briefly, E18
timed pregnant Sprague–Dawley rat was euthanized by CO2
and cervically dislocated in accordance with institutionally
approved animal care. Embryos were dissected and cortices
isolated in Hank's buffer solution without Ca2+ and Mg2+. All
tissue was collected and maintained in ice-cold buffer solution
and, to obtain a single-cell suspension, cerebral cortices were
enzymatically digested at 37°C with warm TrypLe Express for
15–18 min in a water bath. The digestion was stopped by
adding medium (Neurobasal or DMEM) complemented with
10% FCS (fetal calf serum) for 3 min, after this interval the
medium was carefully removed and the cortices, transferred in
Neurobasal/B27 (supplemented with Glutamax and Pen-
Strepto), were mechanically triturated with a sterile fire-
polished Pasteur pipette. Single-cell suspension was well mixed,
counted, and diluted. Finally, cells were plated on poly-L-ornithineFrontiers in Pharmacology | www.frontiersin.org 4(100 µg/ml) coated coverslips inserted into multiwells plates at
the density around 5.0x 104cell/cm2. The primary cultures were
kept at 37°C in humidified atmosphere of 5% CO2 in air. The
culture medium was changed weekly, until the uptake
experiments at 21 DIV, at the end of the 3 weeks of
development of the in vitro culture the percentage
composition of the cell population was distributed with 70 ±
15% of neurons and 30 ± 15% of glial cell (the percentage of
neurons and astrocytes were estimated in three to five non-
overlapping fields from three different cultures, and are expressed
as mean ± SEM), consistent with previous findings (Chiappalone
et al., 2006). Immunofluorescence assays were performed using
rabbit anti-MAP-2 (1:500), mouse anti-GFAP (1:1,000), and
DAPI dye. See a representative image acquired by
epifluorescence microscopy in Figure 3A.
Cellular Uptake of Exosomes
Exosomes, made fluorescent with the PKH67 lipophilic dye, were
dispersed (16 µl) in the same culture medium where the
coverslips were immersed with the neuronal networks and
incubated for 1 h at 37°C in humidified atmosphere of 5%
CO2 in air.
In parallel, as a negative control, the same volume (16 µl) of
control sample was loaded onto other coverslips from the same
neuronal preparation, and left to incubate for 1 h under the same
conditions as above. After the time interval had elapsed, both the
coverslips with the exosomes and those with control sample were
washed repeatedly to remove the excess.
To evaluate the uptake capabilities of the exosomes, the
experiments were repeated on three different neuronal
preparations, developed in vitro for 3 weeks, and the biological
sample was subjected to specific marking to confirm its
neuronal/glial morphology and exosomes uptake. Briefly, the
cells were fixed in 4% PFA, blocked with 3% BSA, and incubated
primarily with rabbit or mouse primary antibodies (over-night at
4°C in humid chamber) and then with Alexa Fluor 546 donkey
anti-mouse and 633 goat anti-rabbit (1h at room temperature).
The following primary antibodies were used: rabbit anti-b III
tubulin (1:500) or rabbit anti-MAP2 (1:500), or rabbit or
mouse anti-GFAP (1:1,000). The excessive antibodies were
washed by PBS. The glass coverslips were mounted with
antifade mounting medium and observed using confocal
microscopy (see above).RESULTS
Gliosomes Obtained From Adult Rat
Cerebral Cortex Are a Purified Preparation
of Cerebrocortical Astrocyte Processes
At confocal microscopy, the astrocyte processes appeared labeled
with the anti-GFAP antibody (a marker identifying astrocytes),
and were negative for synaptophysin, integrin-aM, and RIP
(marke r s fo r the ne rve t e rmina l s , m i c rog l i a , o r
oligodendrocytes, respectively. Figures 1A–I). As a control, weDecember 2019 | Volume 10 | Article 1452
Venturini et al. Exosomes From Astrocyte ProcessesFIGURE 1 | Astrocyte processes obtained from adult rat cerebral cortex. Negligible contamination of gliosomes, positive for the specific glial marker GFAP (A, D, G),
by subcellular no-astrocytic particles. Immunofluorescent assay for synaptophysin (B), RIP (E) or integrin-aM (H) markers for nerve terminals, microglia, and
oligodendrocytes, respectively. As a positive control, the immunofluorescent assay for synaptophysin (J) was performed on cerebral cortical synaptosomes scarcely
contaminated by subcellular GFAP-positive particles (K). Bars (C, F, I, L) represent the percent of positive particles (% ± SEM of positive particles counted in three
to five no-overlapping fields from n = 3 different preparations): GFAP (C, F, I, solid bars; L, empty bar), synaptophysin (C empty bar; L solid bar; L, empty bar), or RIP
or integrin-aM (F or I, respectively; empty bar). Scale bars are indicated in the figures. Western blot analysis of gliosomes and synaptosomes (M, N). The absence of
cross-contamination of the astrocyte processes and nerve terminals is shown (M): MAP2, b III tubulin, and GFAP proteins were used as selective markers for the
synaptosome or gliosome preparations. Presence of the astrocytic markers GFAP and ezrin, and of the exosome markers Alix and Tsg101 in the gliosomes (N).
Electron microscopy image of a cortical astrocyte processes. A single gliosome is shown containing vesicles scattered in the cytoplasm and a multivesicular body
(O). Scale bars: 200 nm. Schematic of a perfusion unit of the apparatus allowing recovery of extracellular vesicles (exosomes) released from the processes during
perfusion (P). For other experimental details, see Materials and Methods.Frontiers in Pharmacology | www.frontiersin.org December 2019 | Volume 10 | Article 14525
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from rat cerebral cortex were positive for synaptophysin and
negative for GFAP (Figures 1J–L). The Western blot analysis
showed the absence of contamination by neural specific proteins
(MAP2 and b III tubulin) in the gliosome preparation, and the
negligible contamination of the cerebral cortical synaptosomes
prepared in parallel (Figure 1M). The findings indicate that
gliosomes are a purified preparation of processes of
cerebrocortical astrocytes, negligibly contaminated by
neuronal, microglial, or oligodendroglial particles. The
processes were also analyzed by Western blot and were found
to express the astrocytic markers GFAP and ezrin, the exosome
endosomal-lysosomal sorting proteins Alix and Tsg101, and
NGB (Figure 1N). The electron microscopy analysis on
gliosomes revealed the presence of multivesicular bodies and
scattered vesicles inside the astrocyte processes (Figure 1O).
Purified Astrocytic Processes Release
Extracellular Vesicles Exhibiting the
Characteristics of Exosomes
The EVs released and recovered in the perfusate from
cerebrocortical astrocyte processes (see Figure 1P for a
scheme of perfusion unit) were firstly analyzed using
nanosight dynamic light-scattering analysis and electronFrontiers in Pharmacology | www.frontiersin.org 6microscopy imaging, and subsequently for the presence of the
exosome specific protein markers Alix and Tsg101. At dynamic
light-scattering analysis, the EVs showed a bell-shaped size
distribution profile, peaking at mode 60 nm (range 50–75) (see
in Figure 2A the tracing of a representative experiment from
three different experiments with similar results). The observed
size is consistent with the theoretical size of exosomes and
previous observations (Skog et al., 2008). The typical cup shape
appearance at the ultrastructural level and their size (electron
microscopy images, Figure 2B) are consistent with previously
reported exosome electronmicroscopy images (see Raposo and
Stoorvogel, 2013). The EVs were verified for the presence of
astrocytic markers, namely for GFAP and ezrin. Using western
blot analysis, we obtained signaling for both GFAP and ezrin in
the EVs recovered from the perfusion collected samples
(Figure 2C), demonstrating the astrocytic source of the
particles collected.
Both the exosome specific protein markers Alix and Tsg101
were present in the vesicles (Figure 2D), confirming that the EVs
recovered in the perfusate from the processes exhibit the features
of exosomes.
Gliosomes and exosomes were also labeled with anti-NGB
antibody (Figure 2E), indicating that exosomes carry
NGB protein.FIGURE 2 | Characterization of rat cerebrocortical astrocyte processes-released exosomes. Size distribution of exosomes released from the astrocyte processes, as
assessed by the zetasizer nano ZS90 particle sizer. Curve shows a representative tracing (from three samples obtained from three different experiments with similar
results) (A). Electron microscopy images of vesicles released from astrocyte processes. Note the cup shape appearance and size, consistent with previously
reported exosome electron microscopy images characteristics (B; scale bar: 100 nm). Presence of astrocytic markers, exosomal markers, and of NGB (C–E).
Western blot for the astrocytic markers GFAP and ezrin in gliosome preparation and in exosomes released from gliosomes (C). Western blot for the exosomal
markers Alix and Tsg101 in gliosome preparation and in gliosome-released exosomes (D). Western blot for NGB in gliosome preparation and in gliosome-released
exosomes (E). For other experimental details, see Materials and Methods.December 2019 | Volume 10 | Article 1452
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Target Neurons and Can Be Internalized
by Neurons
The exosomes released and recovered in the perfusate from
cerebrocortical astrocyte processes were able to target cells in
neuron-astrocyte co-cultures. Notably, in the co-cultures, only
GFAP-negative cells were targeted by the exosomes, while
GFAP-positive astrocytes were not. In particular, we found
that exosomes targeted cells exhibiting the morphological
features of neurons (Figure 3); labeling with the neuronal
markers MAP-2 and b III tubulin confirmed the selective
transfer of astrocyte-released exosomes to neurons (Figures
3B–I; Video 1). Notably, confocal microscopy confirmed the
ability of exosomes to be internalized rather than being attached
to the surface of the neuronal membrane (Figures 3B–H); we
found evidence for exosome presence inside the neurons both at
their projections (Figures 3B–H) and at the perinuclear region
(Figure 3I). Interesting to note, exosome traveling to
perinuclear region was already reported in PC12 cells as well
a s in human- induced p lur ipo tent s t em ce l l s or in
human neuroblastoma cell lines (Tian et al., 2010; Sardar
Sinha et al., 2018).DISCUSSION
Our main finding is represented by the fact that exosomes can be
released from astrocyte processes and selectively target neurons;
these exosomes might transfer NGB of astrocytic origin. The
relevance and the novelty of these findings are to be considered
in light of the following considerations:
-Although it was already demonstrated that exosomes can be
released from cultured astrocytes (Guescini et al., 2010),
astrocytes in culture can only marginally mimic the behavior
of astrocytes in situ. We here report on processes of astrocytes
acutely prepared from adult rat cerebral cortex, thus reflecting
the behavior of astrocyte processes in mature cerebrocortical
neuron-astrocyte networks. Notably, these processes were
positive for ezrin, an astrocytic cytoskeletal protein selective
marker of the perisynaptic astrocyte processes, required for the
astrocyte processes structural plasticity (see Cervetto et al., 2018
and references therein). In the perfusate from the processes we
collected particles that proved to be positive for the specific
protein markers for exosomes, the endosomal-lysosomal sorting
proteins Alix and Tsg101, indicating that exosomes can be
released from the processes. In fact, electron microscopy
imaging indicated the presence of multivesicular bodies in the
processes, consistent with their ability to release exosomes.
Astrocyte processes might therefore participate in a roamer-
type of volume transmission through the release of exosomes.
Thus, the processes are capable of contributing in multiple
modes to the signal transmission in CNS, both receiving
messages and sending messages of different type, and
presumably with different half-life and targets, such as the
gliotransmitters (e.g. glutamate, that can be rapidly taken upFrontiers in Pharmacology | www.frontiersin.org 7and/or activate non synaptic glutamate receptors) and signals
that may be transferred through EVs. Notably, perisynaptic
processes exhibit plasticity and can rapidly change their
morphology, modifying the coverage of pre- and postsynaptic
elements at the synapses (Reichenbach et al., 2010; Bernardinelli
et al., 2014); plasticity of perisynaptic processes has been
reported to result in dramatic changes of the interstitial space
during sleep or pharmacological anesthesia (Xie et al., 2013). We
can hypothesize that the conceivable consequent opening of the
synapses might reduce the "privacy" of synaptic wiring
transmission in favor of volume transmission, suggesting that
astrocyte signaling through volume transmission might have
different relevance and functions depending on physiological
cycles and the state of synaptic coverage. This would contribute
to the shift from a neurocentric to a neuro-astrocentric view of
the brain functioning, as the perisynaptic astrocyte processes
may be the source for both classical volume transmission
through the release of gliotransmitters, and for roamer-type
volume transmission through the release of exosomes. By this
way, the astrocyte processes might be capable of inducing
transient phenotype changes in the receiving cells (see Agnati
et al., 2014 and references therein).
The exosomes released from the astrocyte processes were
found to target neurons. It was already shown that exosomes
from cultured astrocytes could contact co-cultured neurons to
promote neurite outgrowth of neighboring neurons and/or
neuronal survival (see Janas et al., 2016 and references therein;
Frühbeis et al., 2012; Caruso Bavisotto et al., 2019) and could
protect neurons against ischemic damage (see Hira et al., 2018;
Pei et al., 2019; Xu et al., 2019). This is however to our
knowledge, the first evidence indicating that ex-vivo astrocytes
—in particular, astrocyte processes acutely prepared from adult
astrocytes that have matured in neuron-astrocyte network—can
selectively communicate to neurons through exosomes. In the
framework of the complex bidirectional signaling coordinating
the function of the neuron-astrocyte networks the evidence that
the astrocyte processes can release exosomes to target neurons
adds a further mode of astrocyte-to-neuron communication that
might be of significant (and so far uncovered) importance in
physiological as well as in pathological conditions. As a matter of
fact, exosomes transfer from astrocyte might result in a transient
phenotype change of the receiving neurons, e.g. by enrichment in
neuroprotective factors (see below) or by expression of receptors
(see exosomes carrying functionally competent neurotransmitter
receptors to receiving cells; Guescini et al., 2012) making neurons
transiently able to recognize and decode extracellular signals,
with possible relevant neuropharmacological implications. The
ability of astrocyte-derived exosomes to effectively transfer
signals and functions to neurons is a crucial point worth to be
investigated in the future. Also, it remains not understood why
some neurons (and their projections) are preferentially targeted
by exosomes; further investigation is required to understand the
neurochemical characteristics or the attracting pathways of the
neurons/neurona l pro jec t ions to which exosomes
preferentially bind.December 2019 | Volume 10 | Article 1452
Venturini et al. Exosomes From Astrocyte ProcessesFIGURE 3 | Neurons: targets for the exosomes. Confocal images showing exosomes targeting neurons when added to a neuron-astrocyte co-culture.
Characteristics of the neuron-astrocyte co-culture; see coexistence of GFAP-positive (green) astrocytes and MAP2-positive (red) neurons in a representative
epifluorescence microscope image at 21 div and their relative distribution at 3 and 21 div culture (A). DAPI stained was used to marker cellular nucleus. Scale bar is
indicated in the figure. See that exosomes (marked with PKH67, green) preferentially contact GFAP-negative cells, while GFAP-positive astrocytes are not targeted
(blue in B, C, red in J, K). Exosomes selectively target cells positive for the neuronal markers MAP2 (in B, C, D–F) or b III tubulin (red in G-I). The images are the
merge of a single z stack of the two channels (D–F, H–L) or representative maximum intensity projections of the acquired z stacks of the two or three channels
(B–C; G). See in Video 1 the z-axis analysis related to the panel B. Note internalization of exosomes (D–I): evidence for exosome presence inside the neuronal
projections (D–H) and at the perinuclear region (I). A control sample prepared in parallel by omitting the exosome excluded the non-specific labeling of cells (L).
Scale bars are indicated in the figures. For other experimental details, see Materials and Methods.Frontiers in Pharmacology | www.frontiersin.org December 2019 | Volume 10 | Article 14528
Venturini et al. Exosomes From Astrocyte Processes-The exosomes were found to carry NGB. As a matter of fact,
it was initially thought that NGB in mammals was expressed
exclusively in neurons of the nervous system. NGB, however, was
also observed in astrocytes and reactive astrocytes (see Della
Valle et al., 2010 and references therein). In particular, it was
hypothesized that NGB may be produced by astrocytes for
secretion, possibly as a neuroprotective agent for neurons
(Della Valle et al., 2010). Astrocytes, indeed, are recognized to
play multiple roles in diverse pathological conditions in the
brain, playing both neuroprotective and detrimental roles (see
Verkhratsky et al., 2016) The possibility that astrocyte processes
could release NGB through exosomes would allow them to send
long-distance messages to cells, to transiently change their
susceptibility to damage, and to participate in the beneficial
effects of astrocytes in ischemic injury (see Verkhratsky et al.,
2016 and references therein).
Actually, NGB can serve multiple crucial roles in cell defense
and resistance to degeneration, and transferring NGB from
astrocytes might contribute to protecting neurons. In this
respect, it was reported that estradiol regulates NGB expression
both in neurons and astrocytes through ERb-mediated
mechanisms and that this regulation of the expression of NGB
may be part of the neuroprotective mechanisms activated by
estradiol in astrocytes (see references in Guidolin et al., 2014;
Guidolin et al., 2016). As a matter of fact, transferring signals
through exosomes has been proposed to be involved in the
participation of glial cells to neurodegeneration or
neuroprotection (see Verkhratsky et al., 2016; Lafourcade et al.,
2016); by supporting the ability of astrocyte-derived exosomes to
target neurons, our findings indicate that astrocytes might
participate to neuron neuroprotection by transferring NGB
through this mode of astrocyte-neuron communication.
Notably, the roles for exosomes in transferring protective
signals to neurons were already suggested on the basis of data
from cultured astrocytes (Taylor et al., 2007; Wang et al., 2011;
Guitart et al., 2016; Hira et al., 2018; Pascua-Maestro et al., 2019;
Pei et al., 2019; Xu et al., 2019).
-Exosomes, being released from a variety of cells, have been
proposed as peripheral markers for diagnostic-prognostic
purposes in various diseases. They have been also proposed as
peripheral markers for CNS diseases; however, one of the
problems in their reliability as markers, besides the correct
classification of exosomes, is their origin (Raposo and
Stoorvogel, 2013). It is to note that exosomes recovered in the
blood and originating from astrocytes were reported to behave
as marker for stress-induced disease (Gómez-Molina et al.,
2019). Also, recently GFAP-positive exosomes originating
from astrocytomas were found in the blood and were claimed
to be of help to the glioma classification (Van Bodegraven et al.,
2019). Furthermore, astrocyte-derived EVs were found in
periphery in neuroinflammatory conditions or after brain
focal radiation (Dickens et al., 2017; Willis et al., 2017; Cai
et al., 2017). Inaddition to functioningasbiomarkersofdifferent
pathological conditions, the astrocyte-derived exosomes in
blood might also target peripheral organs in the brain-to-
periphery signaling (Dickens et al., 2017; Cai et al., 2017; seeFrontiers in Pharmacology | www.frontiersin.org 9also Gómez-Molina et al., 2019). Worthy of note, we here
indicate that a subcellular region of astrocytes—the processes
that are devoted to sending/receiving signals in the nervous
system—might be primarily involved in signal communication
through exosomes. Notably, the finding that astrocyte-derived
exosomes are posit ive for astrocytic markers al lows
hypothesizing that analysis of these markers could help to
understand the cellular origin of (parental cells originating
the) exosomes that might be recovered in peripheral blood
from healthy or diseased CNS.CONCLUSIONS
In conclusion, our findings for the first time indicate that the
astrocyte processes acutely prepared from astrocytes matured in
a neuron-astrocyte network in CNS might participate to signal
transmission by releasing exosomes, which, in turn might target
near or long-distance targets by volume transmission. The
exosomes released by the processes proved to selectively target
neurons, adding a new non-conventional mode of astrocyte-to-
neuron signal transmission, with unexplored impact on
integrative communication in the CNS and neuropharmacological
implications. Indeed, releasing NGB-carrying exosomes might be a
mode for astrocytes to operate as a signal toprotectneighboringcells
in neuron-astrocyte networks. Also, our findings could help to
understand the parental cell origin of the exosomes that might be
recovered from peripheral blood.DATA AVAILABILITY STATEMENT
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